Bridgestone and the Leukaemia Foundation ‘Celebrate Hope’ on 30th anniversary
Publish Date: 20/5/2016
Celebrating hope for a future where everyone with a blood cancer can be cured will be at the heart of ‘Iridescence’, a spectacular gala ball at the Adelaide Convention Centre on June 25.
The black tie event will commemorate the 30-year charitable partnership between Bridgestone Australia and the Leukaemia Foundation, with all proceeds funding vital research to unlock better treatments for leukaemia, lymphoma, myeloma and related blood disorders.
Australian singer Deni Hines will headline the evening’s entertainment, with support from Adelaide band, The Cast. The fine food and wine on offer will be sure to delight the most fanatical of foodies.
Bill Petch, CEO of the Leukaemia Foundation, said the event would celebrate one of Australia’s longest standing charitable partnerships, while highlighting the need for more research to find better treatments and improving survival for people with blood cancer.In addition to being a proud Principal Partner of the Leukaemia Foundation, Bridgestone Australia provides other very significant and vital financial contributions.
Demonstrating their commitment to the Foundation’s fundraising initiatives, Bridgestone Australia is the Principal Partner of Light the Night and Principal Partner of the Aussie Muscle Car Run. Through the sale of their valve caps, each year Bridgestone Australia funds the Leukaemia Foundation’s Career Grant (valued at $50,000) and also provides vehicles for our Transport Service across the country.
“Thanks to Bridgestone and our loyal supporters, so much has been achieved over an incredible three decades to help families affected by blood cancer,” said Mr Petch.“Families right across the country have access to our range of services, all free of charge, to lighten the burden on them during their loved one’s blood cancer experience and beyond. Meanwhile we’re always motivated by our mission to beat blood cancer by investing in Australia’s best blood cancer research projects that offer potential treatment breakthroughs.
“Not only will Iridescence recognise all the work that has been done so far, it will highlight the need for us to continue working together to ensure that the 60,000 Australians diagnosed with blood cancer each year can achieve a better quality of life during their treatment and, most importantly, have hope for their long term recovery.”
Bridgestone Australia and New Zealand Managing Director Andrew Moffatt said the company was proud of its longstanding partnership with the Leukaemia Foundation.
“In line with Bridgestone’s global mission, and recognising the need to support society, we started to provide patient transport vehicles for the Leukaemia Foundation through our dealer network in 1986. That partnership has been building ever since and has grown to support for this organisation at every level of our business – from dealers to employees to head office,” he said.
“Being able to see first-hand the positive impact our partnership with the Foundation can have on those families facing a diagnosis certainly makes it all worthwhile. This milestone is a time to celebrate the efforts of all our people to assist the Foundation in its Mission to Care but, importantly, it is also a time to continue striving towards its Vision to Cure through the support and funding of grant research.”
Iridescence will light up the Adelaide Convention Centre on Saturday, June 25, beginning with pre-dinner drinks from 6.30pm. Tickets: General - $1700 per table or $180 p/person; Corporate - $3000 per table of 10. Purchase tickets today or call 08 8169 6043 (ticket sales close on Friday, June 10).